Hyperfine, Inc. (HYPR) Form 10-K Annual Reports
Hyperfine, Inc. (HYPR) is a publicly traded company on the Nasdaq, categorized under SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: HYPR
CIK: 1833769
Exchange: Nasdaq
SIC 3845: Electromedical & Electrotherapeutic Apparatus
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Grant Thornton LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerDominic Mills
Audit LocationSan Jose, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-08 | 2026-10-08 | 8-K | 0001193125-26-417437 | View SEC Doc Filr Page |
| 8-K | 2026-09-18 | 2026-09-17 | 8-K | 0001193125-26-395525 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-24 | 4 | 0001193125-26-365147 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-24 | 4 | 0001193125-26-365144 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001193125-26-338015 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001193125-26-337963 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-28 | — | SCHEDULE 13G Filing | 0002012383-26-002521 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | 4 | 0001193125-26-257953 | View SEC Doc Filr Page |
| 4 | 2026-05-27 | 2026-05-26 | 4 | 0001193125-26-241962 | View SEC Doc Filr Page |
| 4 | 2026-05-27 | 2026-05-26 | 4 | 0001193125-26-241960 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-22 | 4 | 0001193125-26-237054 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-22 | 4 | 0001193125-26-237052 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-22 | 4 | 0001193125-26-237050 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-22 | 4 | 0001193125-26-237045 | View SEC Doc Filr Page |
| EFFECT | 2026-05-21 | — | EFFECT Filing | 9999999995-26-001730 | View SEC Doc Filr Page |
| 8-K | 2026-05-21 | 2026-05-21 | 8-K | 0001193125-26-234426 | View SEC Doc Filr Page |
| CORRESP | 2026-05-19 | — | CORRESP Filing | 0001193125-26-230703 | View SEC Doc Filr Page |
| UPLOAD | 2026-05-18 | — | UPLOAD Filing | 0000000000-26-005084 | View SEC Doc Filr Page |
| S-3 | 2026-05-12 | — | S-3 | 0001193125-26-219646 | View SEC Doc Filr Page |
| 10-Q | 2026-05-12 | 2026-03-31 | 10-Q | 0001193125-26-219428 | View SEC Doc Filr Page |
| 8-K | 2026-05-12 | 2026-05-12 | 8-K | 0001193125-26-219380 | View SEC Doc Filr Page |
| ARS | 2026-04-08 | 2025-12-31 | ARS | 0001193125-26-147643 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-08 | — | DEFA14A | 0001193125-26-147638 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-08 | 2026-05-21 | DEF 14A | 0001193125-26-147623 | View SEC Doc Filr Page |
| 4 | 2026-04-01 | 2026-03-31 | 4 | 0001193125-26-138149 | View SEC Doc Filr Page |